Search for: "Bayer Corp" Results 461 - 480 of 505
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Aug 2008, 1:23 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert Jacobsen v… [read post]
15 Aug 2008, 12:56 pm
§ 1407, Unopposed by Certain Class Action Plaintiffs but Opposed by Others, but Concludes Class Actions should be Transferred to Southern District of Florida Eighteen class actions were filed in 14 different federal district courts against various defendants, including Bayer Corp., Bayer Healthcare Pharmaceuticals, Bayer Healthcare, LLC, Bayer AG, and Bayer Healthcare AG (collectively “Bayer”), alleging… [read post]
9 Aug 2008, 1:50 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: The end of William Patry’s blog: (Patry Copyright Blog), (Excess Copyright), (Patently-O), (Chicago IP Litigation Blog), (Michael Geist), (The Fire of Genius), (Techdirt), (Patry Copyright Blog), Kitchin J clarifies scope of biotech patents, in particular gene sequence patents: Eli Lilly & Co v Human Genome Sciences: (Managing… [read post]
27 Jun 2008, 10:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
23 May 2008, 1:03 am
: (Innovationpartners), ICANN reforms threaten voice of IP owners: (Managing Intellectual Property), INTA 130th annual meeting – a report: (IPKat), (Intellectual Property Watch), (IAM), INTA’s online Committee Portal premiers: (Managing Intellectual Property), Hans Van Bylen tells how careful brand management and exploitation of ‘glocal’ products helped Henkel become global player: (Managing Intellectual Property), Records number of IP owners applied for… [read post]
15 May 2008, 8:43 am
[Posted 11/05/2007] FDA announced that, at the agency's request, Bayer Pharmaceuticals Corp. has agreed to a marketing suspension of Trasylol (aprotinin injection), a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death. [read post]
2 May 2008, 7:00 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
28 Apr 2008, 11:00 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
27 Apr 2008, 8:15 pm
Bayer Corp Long Term    Eastern District of Tennessee at Knoxville 08a0220n.062008/04/24 USA v. [read post]
17 Apr 2008, 10:39 am
Novartis Pharmaceuticals Corp., ___ F. [read post]
4 Apr 2008, 1:00 am
, (Ars Technica), (Patent Prospector), (Washington State Patent Law Blog), (IP Law Observer), (PLI), (PLI), (IP Updates), (Patent Docs), (Peter Zura’s 271 Patent Blog), (The Invent Blog), (IP Spotlight), (Just a Patent Examiner), (Techdirt), (Patent Baristas), (IPBiz), (IPBiz), (Patently-O), (IAM), (IP ThinkTank), (Against Monopoly), (Against Monopoly), (IP Law360), (Hal Wegner), (Ladas & Parry), Global Global - General Virtual monopoly – four strategic choices:… [read post]
28 Mar 2008, 5:25 am
Bayer Pharmaceuticals Corp., No. 3:07 CV-660, slip op. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
5 Mar 2008, 3:39 pm by Jared Faerber
   The most disturbing part of this is that not until November 2007 did Bayer Pharmaceuticals Corp., the manufacturer of Trasylol, agree to a marketing suspension. [read post]